{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:40:26Z","timestamp":1785602426215,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006679","name":"Kobayashi Magobe Memorial Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.euroneuro.2019.07.137","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T07:49:45Z","timestamp":1564127385000},"page":"1041-1050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Anti-NMDA-receptor antibody in initial diagnosis of mood disorder"],"prefix":"10.1016","volume":"29","author":[{"given":"Hiroki","family":"Kawai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5498-551X","authenticated-orcid":false,"given":"Shinji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunta","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Yada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3598-798X","authenticated-orcid":false,"given":"Kota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Okahisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soshi","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanbayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-2840","authenticated-orcid":false,"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2019.07.137_bib0001","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","article-title":"The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data","volume":"6","author":"Al-Diwani","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0002","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12888-016-0948-9","article-title":"Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study","volume":"8","author":"Ando","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0003","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/WCO.0000000000000087","article-title":"Autoimmune encephalitis as differential diagnosis of infectious encephalitis","volume":"27","author":"Armangue","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0004","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/mp.2016.125","article-title":"All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class","volume":"22","author":"Castillo-G\u00f3mez","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0005","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0006","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0008","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0896-6273(00)80715-1","article-title":"Activation of Heschl's gyrus during auditory hallucinations","volume":"22","author":"Dierks","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0009","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/acps.12963","article-title":"Frequency of neuropsychiatric disturbances in anti-NMDA receptor encephalitis","volume":"138","author":"Espinola-Nadurille","year":"2018","journal-title":"Acta. Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/pcn.12867","article-title":"Catatonia in patients with anti-NMDA receptor encephalitis","author":"Espinola-Nadurille","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1984.tb09689.x","article-title":"Glutamate: a neurotransmitter in mammalian brain","volume":"42","author":"Fonnum","year":"1984","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0012","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1017\/S1461145708009231","article-title":"Treatment of bipolar disorder: a systematic review of available data and clinical perspectives","volume":"11","author":"Fountoulakis","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0013","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1017\/S1461145710000544","article-title":"Repeated electroconvulsive shock (ECS) alters the phosphorylation of glutamate receptor subunits in the rat hippocampus","volume":"13","author":"Fumagalli","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0014","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"Psychiatric Serv."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0016","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0017","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","volume":"19","author":"Hammer","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0018","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","article-title":"Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor","volume":"90","author":"Hara","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0019","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0020","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0021","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/01.wnl.0000278388.90370.c3","article-title":"Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal","volume":"70","author":"Iizuka","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0022","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.mp.4001551","article-title":"Glutamate as a therapeutic target in psychiatric disorders","volume":"9","author":"Javitt","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0023","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2014.10.007","article-title":"Anti-NMDA receptor encephalitis, autoimmunity, and psychosis","volume":"176","author":"Kayser","year":"2016","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0024","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0026","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2215-0366(16)30375-3","article-title":"Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study","volume":"4","author":"Lennox","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0027","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0006-3223(99)00284-X","article-title":"Increased cerebrospinal fluid glutamine levels in depressed patients","volume":"47","author":"Levine","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0028","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0029","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.12122","article-title":"Pharmacological management of unipolar depression","volume":"443","author":"Malhi","year":"2013","journal-title":"Acta. Psychiatrica Scand. Suppl."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1440-1819.2012.02324.x","article-title":"Electroconvulsive therapy can improve psychotic symptoms in anti-NMDA-receptor encephalitis","volume":"66","author":"Matsumoto","year":"2012","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0031","doi-asserted-by":"crossref","first-page":"1007S","DOI":"10.1093\/jn\/130.4.1007S","article-title":"Glutamate as a neurotransmitter in the brain: review of physiology and pathology","volume":"130","author":"Meldrum","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0032","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00221-017-4917-4","article-title":"How do the two visual streams interact with each other?","volume":"235","author":"Milner","year":"2017","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0033","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0034","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.166.3903.386","article-title":"Brain lesions in an infant rhesus monkey treated with monosodium glutamate","volume":"166","author":"Olney","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0036","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpneuro0493","article-title":"A patient with encephalitis associated with NMDA receptor antibodies","volume":"3","author":"Sansing","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"issue":"31","key":"10.1016\/j.euroneuro.2019.07.137_bib0037","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.neuropsych.18010005","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis: a review of psychiatric phenotypes and management considerations: a report of the American neuropsychiatric association committee on research","volume":"2019","author":"Sarkis","year":"2019","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0038","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.euroneuro.2019.07.137_bib0039","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/JCP.0000000000000439","article-title":"Anti-inflammatory therapy and immunotherapy were partially effective in a patient with anti-N-methyl-D-aspartate receptor antibodies and a special subgroup of treatment-resistant schizophrenia","volume":"36","author":"Senda","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5498\/wjp.v4.i4.80","article-title":"Memantine: new prospective in bipolar disorder treatment","volume":"4","author":"Serra","year":"2014","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0041","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/10253890.2015.1045868","article-title":"Autonomic dysfunction and heart rate variability in depression","volume":"18","author":"Sgoifo","year":"2015","journal-title":"Stress"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0042","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0006-3223(03)00420-7","article-title":"Social and economic burden of mood disorders","volume":"54","author":"Simon","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0043","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4088\/JCP.v64n0916","article-title":"Suicidal ideation and attempts among psychiatric patients with major depressive disorder","volume":"64","author":"Sokero","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0044","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/jamapsychiatry.2014.469","article-title":"Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited","volume":"71","author":"Steiner","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0046","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.schres.2013.04.034","article-title":"Catatonia in DSM-5","volume":"150","author":"Tandon","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0047","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0048","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-244X-12-37","article-title":"Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features","volume":"12","author":"Tsutsui","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0049","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4088\/JCP.v66n1116","article-title":"Suicidal ideation and attempts in bipolar I and II disorders","volume":"66","author":"Valtonen","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0050","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0000000000000126","article-title":"Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis","volume":"82","author":"Viaccoz","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0051","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000480514","article-title":"Comparisons between psychiatric symptoms of patients with anti-NMDAR encephalitis and new-onset psychiatric patients","volume":"75","author":"Wang","year":"2017","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0052","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.brs.2018.11.016","article-title":"Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: a systematic review of cases","volume":"12","author":"Warren","year":"2019","journal-title":"Brain Stimul."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0053","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/acps.12941","article-title":"Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis","volume":"138","author":"Warren","year":"2018","journal-title":"Acta. Psychiatrica Scand."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0054","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5698\/1535-7511-16.6.369","article-title":"Epilepsy and the sensory systems","volume":"16","author":"Wolf","year":"2016","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.euroneuro.2019.07.137_bib0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1176\/appi.neuropsych.16050101","article-title":"Anti-NMDA receptor antibody positivity and presentations without seizure, involuntary movement, hypoventilation, or tumor: a systematic review of the literature","volume":"29","author":"Yoshimura","year":"2017","journal-title":"J. Neuropsychiatry Clin. Neurosci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19304341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19304341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:53:25Z","timestamp":1760378005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X19304341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0924977X19304341"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.07.137","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-NMDA-receptor antibody in initial diagnosis of mood disorder","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.07.137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}